Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...

Gastrointestinal stromal tumors; Ki-67 antigen; Tumor suppressor protein p53 ... CONCLUSION: The most common site was the small intestine and 80% had a malignant potential justifying the high ...

In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

THE small intestine comprises the ... should immediately arouse suspicion of a tumor and lead to further investigation. At this hospital, the routine gastrointestinal series includes the giving ...

EDTA-plasma Tumor M2-PK is a useful tool in diagnosis and/or surveillance of gastrointestinal tumors. Fecal Tumor M2-PK testing is a good noninvasive screening parameter for colorectal cancer with ...

OBJECTIVE: This study retrospectively reviewed 46 cases of gastric gastrointestinal stromal tumors treated by endoluminal endoscopic full-thickness resection (EFR) microsurgery in our gastrointestinal ...

The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST. The study will use ... expected to require treatment ...

Retrospective review of subsequent treatments (tx) for esophagogastric adenocarcinomas (EGA) refractory to FOLFOX. This is an ASCO Meeting Abstract from the 2017 Gastrointestinal Cancers Symposium.